Millennium Management’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-39
| Closed | -$23K | – | 5177 |
|
|
2022
Q3 | $23K | Sell |
39
-58
| -60% | -$34.2K | ﹤0.01% | 4956 |
|
|
2022
Q2 | $61K | Buy |
97
+90
| +1,286% | +$56.6K | ﹤0.01% | 4798 |
|
|
2022
Q1 | $8K | Sell |
7
-15
| -68% | -$17.1K | ﹤0.01% | 5078 |
|
|
2021
Q4 | $32K | Buy |
22
+2
| +10% | +$2.91K | ﹤0.01% | 5040 |
|
|
2021
Q3 | $61K | Buy |
20
+9
| +82% | +$27.5K | ﹤0.01% | 4976 |
|
|
2021
Q2 | $35K | Buy |
11
+1
| +10% | +$3.18K | ﹤0.01% | 4913 |
|
|
2021
Q1 | $42K | Buy |
10
+3
| +43% | +$12.6K | ﹤0.01% | 4383 |
|
|
2020
Q4 | $19K | Sell |
7
-2
| -22% | -$5.43K | ﹤0.01% | 4020 |
|
|
2020
Q3 | $23 | Buy |
+9
| New | +$23 | ﹤0.01% | 3520 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | -$301K | – | 3717 |
|
|
2018
Q1 | $301K | Buy |
+1
| New | +$301K | ﹤0.01% | 2981 |
|
|
2017
Q4 | – | Sell |
-1
| Closed | -$249K | – | 3402 |
|
|
2017
Q3 | $249K | Sell |
1
-1
| -50% | -$249K | ﹤0.01% | 2881 |
|
|
2017
Q2 | $530K | Buy |
2
+1
| +100% | +$265K | ﹤0.01% | 2540 |
|
|
2017
Q1 | $422K | Sell |
1
-1
| -50% | -$422K | ﹤0.01% | 2665 |
|
|
2016
Q4 | $762K | Buy |
+2
| New | +$762K | ﹤0.01% | 2211 |
|